Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Pieter M. Ter Wee"'
Autor:
Susanne Stads, Louise Schilder, S Azam Nurmohamed, Frank H Bosch, Ilse M Purmer, Sylvia S den Boer, Cynthia G Kleppe, Marc G Vervloet, Albertus Beishuizen, Armand R J Girbes, Pieter M Ter Wee, Diederik Gommers, A B Johan Groeneveld, Heleen M Oudemans-van Straaten, CASH study group
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0197301 (2018)
INTRODUCTION:Acute kidney injury (AKI) requiring renal replacement therapy (RRT) is associated with high mortality. The creatinine-based stage of AKI is considered when deciding to start or delay RRT. However, creatinine is not only determined by ren
Externí odkaz:
https://doaj.org/article/3ecfa4abf947495692a5a90a1ff5f996
Autor:
Frans J. van Ittersum, Marc G. Vervloet, Tiny Hoekstra, Pieter M. ter Wee, Annet Bouma-de Krijger
Publikováno v:
Clinical kidney journal, 12(5), 678-685. Oxford University Press
Clinical Kidney Journal
Bouma-de Krijger, A, van Ittersum, F J, Hoekstra, T, ter Wee, P M & Vervloet, M G 2019, ' Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3 ', Clinical kidney journal, vol. 12, no. 5, pp. 678-685 . https://doi.org/10.1093/ckj/sfz027
Clinical Kidney Journal
Bouma-de Krijger, A, van Ittersum, F J, Hoekstra, T, ter Wee, P M & Vervloet, M G 2019, ' Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3 ', Clinical kidney journal, vol. 12, no. 5, pp. 678-685 . https://doi.org/10.1093/ckj/sfz027
Background High concentrations of both phosphate and fibroblast growth factor 23 (FGF23) observed in chronic kidney disease (CKD) are associated with an increased risk of cardiovascular morbidity and mortality. Pulse wave velocity (PWV) is a surrogat
Autor:
Neelke C van der Weerd, Claire H Den Hoedt, Peter J Blankestijn, Michiel L Bots, Marinus A van den Dorpel, Renée Lévesque, Albert H A Mazairac, Menso J Nubé, E Lars Penne, Pieter M ter Wee, Muriel P C Grooteman, CONTRAST Investigators
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e94434 (2014)
Resistance to erythropoiesis stimulating agents (ESA) is common in patients undergoing chronic hemodialysis (HD) treatment. ESA responsiveness might be improved by enhanced clearance of uremic toxins of middle molecular weight, as can be obtained by
Externí odkaz:
https://doaj.org/article/55d07ef8cb564c728762fc3e7ca98fec
Publikováno v:
Nephrology Worldwide ISBN: 9783030568894
Nephrology Worldwide, 581-591
STARTPAGE=581;ENDPAGE=591;TITLE=Nephrology Worldwide
ter Wee, P M, Nurmohamed, S A & van Wijk, J A E 2021, Nephrology in the Netherlands . in Nephrology Worldwide . Nephrology Worldwide, Springer International Publishing, pp. 581-591 . https://doi.org/10.1007/978-3-030-56890-0_43
Nephrology Worldwide, 581-591
STARTPAGE=581;ENDPAGE=591;TITLE=Nephrology Worldwide
ter Wee, P M, Nurmohamed, S A & van Wijk, J A E 2021, Nephrology in the Netherlands . in Nephrology Worldwide . Nephrology Worldwide, Springer International Publishing, pp. 581-591 . https://doi.org/10.1007/978-3-030-56890-0_43
Nephrology in the Netherlands was organized as a medical society in 1972. In the Netherlands, everybody is obligatory insured. Within the insurance, all care for chronic kidney disease, end-stage renal disease and transplantation is covered. With a p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92759edc1e0b1c0b46a918814934f1ca
https://doi.org/10.1007/978-3-030-56890-0_43
https://doi.org/10.1007/978-3-030-56890-0_43
Autor:
Andrea W.D. Stavenuiter, Frans J. van Ittersum, Marc G. Vervloet, Pieter M. ter Wee, Karima Farhat, Robert H.J. Beelen
Publikováno v:
Farhat, K, Stavenuiter, A W D, Vervloet, M G, ter Wee, P M, Beelen, R H J & van Ittersum, F J 2018, ' Effects of oral paricalcitol and calcitriol treatment on peritoneal membrane characteristics of peritoneal dialysis patients — A pilot study ', Peritoneal Dialysis International, vol. 38, no. 3, pp. 220-228 . https://doi.org/10.3747/pdi.2017.00150
Peritoneal dialysis international, 38(3), 220-228. Multimed Inc.
Peritoneal Dialysis International, 38(3), 220-228. Multimed Inc.
Peritoneal dialysis international, 38(3), 220-228. Multimed Inc.
Peritoneal Dialysis International, 38(3), 220-228. Multimed Inc.
BackgroundLong-term peritoneal dialysis (PD) is frequently complicated by technique failure preceded by peritoneal remodeling. Vitamin D has potent immunomodulatory characteristics: anti-inflammatory, anti-angiogenic, anti-fibrotic properties, and in
Autor:
Tiny Hoekstra, Adriaan Honig, Prataap K. Chandie Shaw, Tessa O. van den Beukel, Louis-Jean Vleming, Gertrud L. G. Haverkamp, Pieter M. ter Wee, Carl E.H. Siegert, Yves F. C. Smets, Friedo W. Dekker, Wim L. Loosman
Publikováno v:
Journal of Immigrant and Minority Health, 20(6), 1339-1346
JOURNAL OF IMMIGRANT AND MINORITY HEALTH, 20(6), 1339-1346. Springer New York
Journal of immigrant and minority health, 20(6), 1339-1346. Springer New York
Loosman, W L, Haverkamp, G L G, van den Beukel, T O, Hoekstra, T, Dekker, F W, Chandie Shaw, P K, Smets, Y F C, Vleming, L-J, ter Wee, P M, Siegert, C E H & Honig, A 2018, ' Depressive and Anxiety Symptoms in Dutch Immigrant and Native Dialysis Patients ', Journal of immigrant and minority health, vol. 20, no. 6, pp. 1339-1346 . https://doi.org/10.1007/s10903-018-0722-9
JOURNAL OF IMMIGRANT AND MINORITY HEALTH, 20(6), 1339-1346. Springer New York
Journal of immigrant and minority health, 20(6), 1339-1346. Springer New York
Loosman, W L, Haverkamp, G L G, van den Beukel, T O, Hoekstra, T, Dekker, F W, Chandie Shaw, P K, Smets, Y F C, Vleming, L-J, ter Wee, P M, Siegert, C E H & Honig, A 2018, ' Depressive and Anxiety Symptoms in Dutch Immigrant and Native Dialysis Patients ', Journal of immigrant and minority health, vol. 20, no. 6, pp. 1339-1346 . https://doi.org/10.1007/s10903-018-0722-9
Due to continuing migration there is more interest in the mental health status of immigrants. The aim of this study is to determine the prevalence of depressive/anxiety symptoms in immigrant and native dialysis patients, and to explore if patient cha
Publikováno v:
Abrahams, A C, Rüger, W, ter Wee, P M, van Ittersum, F J & Boer, W H 2017, ' Improved outcome of enteric peritonitis in peritoneal dialysis patients aged 50 years and older with temporary discontinuation of peritoneal dialysis and intravenous meropenem ', Peritoneal Dialysis International, vol. 37, no. 3, pp. 298-306 . https://doi.org/10.3747/pdi.2016.00147
Peritoneal Dialysis International, 37(3), 298-306. Multimed Inc.
Peritoneal Dialysis International, 37(3), 298-306. Multimed Inc.
Background Peritonitis is a major cause of morbidity, mortality, and technique failure in peritoneal dialysis (PD) patients, especially when caused by enteric microorganisms (EM). We have implemented a treatment protocol specifically aimed at improvi
Autor:
Caroline Douma, Robert H.J. Beelen, Karima Farhat, Evelina Ferrantelli, Frans J. van Ittersum, Pieter M. ter Wee
Publikováno v:
Farhat, K, Douma, C E, Ferrantelli, E, ter Wee, P M, Beelen, R H J & van Ittersum, F J 2017, ' Effects of conversion to a bicarbonate/lactate-buffered, neutral-pH, low-GDP PD regimen in prevalent PD : A 2-year randomized clinical trial ', Peritoneal Dialysis International, vol. 37, no. 3, pp. 273-282 . https://doi.org/10.3747/pdi.2015.00031
Peritoneal Dialysis International, 37(3), 273-282. Multimed Inc.
Peritoneal Dialysis International, 37(3), 273-282. Multimed Inc.
BackgroundThe use of pH-neutral peritoneal dialysis (PD) fluids low in glucose degradation products (GDP) may better preserve the peritoneal membrane and have fewer systemic effects. The effects of conversion from conventional to neutral-pH, low-GDP
Publikováno v:
Nephron, 134(4), 215-220. KARGER
Adema, A Y, de Jong, M A, de Borst, M H, ter Wee, P M & Vervloet, M G 2016, ' Phosphate Binding Therapy to Lower Serum Fibroblast-Growth-Factor-23 Concentrations in Chronic Kidney Disease: Rationale and Study Design of the Sevelamer on FGF23 Trial (SoFT) ', Nephron, vol. 134, no. 4, pp. 215-220 . https://doi.org/10.1159/000448184
Nephron, 134(4), 215-220. S. Karger AG
Adema, A Y, de Jong, M A, de Borst, M H, ter Wee, P M & Vervloet, M G 2016, ' Phosphate Binding Therapy to Lower Serum Fibroblast-Growth-Factor-23 Concentrations in Chronic Kidney Disease: Rationale and Study Design of the Sevelamer on FGF23 Trial (SoFT) ', Nephron, vol. 134, no. 4, pp. 215-220 . https://doi.org/10.1159/000448184
Nephron, 134(4), 215-220. S. Karger AG
Background: Increased levels of phosphate and fibroblast growth factor-23 (FGF23) are strong predictors of cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD). Preliminary data suggest that interventions lowering gast
Autor:
Michel Aparicio, Daniel Teta, Pieter M. ter Wee, Anne Kolko, Philippe Chauveau, Christoph Wanner, Siren Sezer, Vincenzo Bellizzi, Denis Fouque, Juan Jesus Carrero, Xu Hong, Lina Johansson, Pablo Molina, Katrina L. Campbell
Publikováno v:
Nephrology Dialysis Transplantation
Nephrology Dialysis Transplantation, Oxford University Press (OUP), 2018, 33 (5), pp.725-735. ⟨10.1093/ndt/gfx085⟩
Chauveau, P, Aparicio, M, Bellizzi, V, Campbell, K, Hong, X, Johansson, L, Kolko, A, Molina, P, Sezer, S, Wanner, C, Ter Wee, P M, Teta, D, Fouque, D, Carrero, J J & European Renal Nutrition (ERN) Working Group of the European Renal Association–European Dialysis Transplant Association (ERA-EDTA) 2018, ' Mediterranean diet as the diet of choice for patients with chronic kidney disease ', Nephrology, Dialysis, Transplantation, vol. 33, no. 5, pp. 725-735 . https://doi.org/10.1093/ndt/gfx085
Nephrology Dialysis Transplantation, Oxford University Press (OUP), 2018, 33 (5), pp.725-735. ⟨10.1093/ndt/gfx085⟩
Chauveau, P, Aparicio, M, Bellizzi, V, Campbell, K, Hong, X, Johansson, L, Kolko, A, Molina, P, Sezer, S, Wanner, C, Ter Wee, P M, Teta, D, Fouque, D, Carrero, J J & European Renal Nutrition (ERN) Working Group of the European Renal Association–European Dialysis Transplant Association (ERA-EDTA) 2018, ' Mediterranean diet as the diet of choice for patients with chronic kidney disease ', Nephrology, Dialysis, Transplantation, vol. 33, no. 5, pp. 725-735 . https://doi.org/10.1093/ndt/gfx085
International audience; Traditional dietary management of chronic kidney disease (CKD) focuses on the quantity within the diet of energy and protein, and the restriction of single micronutrients, with little mention of dietary quality. Dietary patter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33fce1a3d31f76987711817712907c4c
https://hal.archives-ouvertes.fr/hal-01847504
https://hal.archives-ouvertes.fr/hal-01847504